Park, Eunyoung
Rawson, Shaun http://orcid.org/0000-0002-2973-2630
Schmoker, Anna http://orcid.org/0000-0003-2830-5650
Kim, Byeong-Won http://orcid.org/0000-0002-7722-0090
Oh, Sehee
Song, Kangkang
Jeon, Hyesung http://orcid.org/0000-0002-0034-5469
Eck, Michael J. http://orcid.org/0000-0003-4247-9403
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (PO1CA154303, P50CA165962)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 29 September 2022
Accepted: 19 July 2023
First Online: 29 July 2023
Change Date: 7 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-41365-9
Competing interests
: M.J.E. receives or has received sponsored research support from Novartis, Sanofi, Takeda, and Springworks Therapeutics and consulting income or honoraria from Novartis, H3 Biomedicine and Ikena Oncology. The remaining authors declare no competing interests.